Radequinil
Radequinil (AC-3933) is a benzodiazepine receptor (BzR) partial inverse agonist. AC-3933 binds to GABA (-) and GABA (+) ligand with Kis of 5.15 and 6.11 nM, respectively[1].
Product Specifications
CAS Number
[219846-31-8]
Product Name Alternative
AC-3933
UNSPSC
12352005
Target
GABA Receptor
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel; Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/radequinil.html
Purity
99.25
Solubility
DMSO : 10 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C1NC2=CC=NC(C3=CC(OC)=CC=C3)=C2C=C1C4=NOC(C)=N4
Molecular Formula
C18H14N4O3
Molecular Weight
334.33
References & Citations
[1]Hashimoto T, et al. Pharmacological properties of AC-3933, a novel benzodiazepine receptor partial inverse agonist. Neuroscience. 2014 Jan 3;256:352-9.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture and light)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
abx442781 100 µg
Gamma-Aminobutyric Acid Receptor Subunit Alpha-5 (GABRA5) Antibody (APC)
Ask
View Details 
GTR15142437 1 Vial
Lentiviral mouse Rnf165 shRNA (UAS) - Lentiviral mouse Rnf165 shRNA (UAS, GFP) (100)
Ask
View Details 
M2865-10B-AP 100 µL
MEK1, MEK2, phosphorylated (Ser218/222, Ser222/226) (MAPK/ERK Kinase 1, MEK 1, Dual Specificity Mitogen-activated Protein Kinase Kinase 1, MAP Kinase Kinase 1, MAP2K1, MAPKK 1, MKK1, PRKMK1, ERK Activator Kinase 1 / MAPK/ERK Kinase 2, Dual Specificity Mitogen-activated Protein Kinase Kinase 2, MAP Kinase Kinase 2, MAP2K2, MAPKK 2, MKK2, PRKMK2, ERK Activator Kinase 2) (AP) discontinued
Ask
View Details